semaglutide for heart health protects beyond weight loss benefits Evaluating the Cardiovascular Benefits of

Are you ready to explore whether Mounjaro or other advanced therapies fit your health goals

Other long-term trials designed to evaluate whether SGLT2 inhibitors have renal protective effects in participants with T2D, and without T2D but with or without chronic kidney disease and macroalbuminuria are ongoing (e.g., the Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy (CREDENCE) study, NCT02065791

Dose decisions should be individualized

The simplest strategy is to increase fibre gradually, prioritise variety (plants, legumes, whole grains), and avoid sudden fibre leaps that trigger bloating

Wegovy , a higher-dose version, is specifically approved for obesity and delivers stronger appetite suppression

The order also covers amendments, verification, and a deficiency and dispute resolution process